Ingen Technologies

IGNT

Medical - Instruments & Supplies · Healthcare

Price

$0.00

+0.00 (+0.00%)

Market Cap

$4,480

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Share count falling — buybacks

−80.2% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 8.4M (2011) → 1.7M (2015)

Ingen Technologies is a small medical device company that makes oxygen-related products for patients who need help breathing. Its main product is a portable oxygen system designed to work reliably in extreme temperatures and remote locations, targeting patients with chronic respiratory conditions like COPD. The company sells primarily to healthcare providers and patients in the United States.

Ingen generates revenue through direct product sales and has an unusually high gross margin, suggesting low manufacturing costs relative to its selling price. However, the deeply negative operating margin signals that the company spends far more on overhead and operations than it currently earns in revenue, which is common for very early-stage medical device firms. The biggest risk facing Ingen is its extremely small size and limited commercial scale, meaning it must significantly grow sales volume or secure outside funding to reach financial sustainability.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-92.8% YoY

YoY Growth Rate

Revenue declining

EPS Growth

EPS data limited

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

29.9%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$113 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Ingen Technologies has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

89.4%

Premium pricing power — 89.4% gross margin

Operating Margin

-13884.5%

Losing money on operations — -13884.5%

ROCE

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

-64.3%

Shrinking sales (-64.3% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-342.0%

Burning cash (-342.0%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial